top of page

Posterior Eye Metastasis

Introduction

Metastasis is a state of cancer where the cancerous cells invade a different part of the body to form secondary tumours. Due to the mobile nature and immortal nature, the cells are able to adapt to the new environment.
- The form their own microenvironment, providing their own vasculature and supply to survive and develop
- Cancer staging is given by TNM, or initial site of the tumour, if it has spread to nymph nodes, and where in the body it has spread.

Estimated cumulative lifetime of 0.1-0.25%
- Microscopic metastatic intraocular lesions estimated in at least 1 of 5 eyes to 10% people at time of death
- Eye tumours are not always detected until shortly before death when patient is already in palliation and terminal stages of cancer
- For the eye, dude to the vasculature of the choroid, it is the most common place for metastasis

Dead Giveaways

Anatomical-Mechanical Entrapment Theory

  • Proposed by Ewing 1928

  • Tumour cells follow circulation draining from the primary tumour, and are retained non-specifically in the capillary bed of the first organ encountered

  • So in the choroid, due to the short posterior arteries being the preferential route for embolic cells, a similar theory is applied for tumour cells

  • Due to the blood retinal barrier, secondary tumours are typically localised to the choroid.

  • Additionally, the short posterior arteries do not extend all the way to ciliary body or iris, which may explain why they are less affected as well.


Seed and Soil Theory

  • Proposed by Paget 1889

  • Depends on blood flow, and the choroid has one of the most vascular tissues in the body.

    • 0.01% of cardiac outflow is directed to the eye, which is around 0.6-0.8 ml/min

    • But 80-85% goes to the choroid

  • The seed or the tumour is placed in an environment or soil that provides nutritional benefit to it, allowing for less drastic adaptation, and hence growing into a secondary tumour

diagnostic features

Origin of Metastasis

  • Realistically, can be from anywhere in the body

  • 40-53% are from breast cancer

  • 20-29% are from lung cancer


Non-specific Presentation

  • May not be the case for all metastasised tumours

  • Can be multifocal and bilateral in 1/4 cases

  • Usually <3mm thick with overlying RPE changes

  • Symptoms depends on SRF, location and size

2025, made by Eric Qin. UNSW. SOVS

bottom of page